O'CONNOR DANIEL J. (Chief Executive Officer) reported 1 transaction at ZYVERSA THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/10/2022ACC: 0001213900-22-011644
DirectorOfficer· Chief Executive Officer
Since Dec 2021
+19.21K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
42.61K acquired · 23.40K disposed
Non-Derivative Transactions1
Class A Common Stock
Indirect
Shares
+42.01K
Price / share
—
Trade value
—
% of position
New position
1/6/2022
0.00→42.01K
Total
Net shares
+42.01K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Indirect | 1/6/2022 | J · J | +42.01K | — | — | New position | 0.00 | 42.01K |
| Total | +42.01K | $0.00 | ||||||
Derivative Transactions2
Class B common stock
Indirect
Converts to
Class A common stock
23.40K shares
Shares
−23.40K
Strike price
Held after
201.24K
Exercisable
—
1/6/2022
Class B common stock
Indirect
Converts to
Class A common stock
609.00 shares
Shares
+609.00
Strike price
Held after
201.85K
Exercisable
—
1/6/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Class B common stock Indirect | Class A common stock23.40K shares | 1/6/2022 | J · J | −23.40K | — | 201.24K | |
| Class B common stock Indirect | Class A common stock609.00 shares | 1/6/2022 | J · J | +609.00 | — | 201.85K |